Science Explorer Back to mapMap

Most cited papers from Syreon Research Institute (Hungary)

What are the most cited papers from Syreon Research Institute (Hungary)?

The most cited paper from Syreon Research Institute (Hungary) is "Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force" (Praveen Thokala, Nancy J. Devlin, Kevin Marsh et al., 2016), with 755 citations. Next come "Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force" (486) and "A systematic review of the health-related quality of life and economic burdens of anorexia nervosa, bulimia nervosa, and binge eating disorder" (396).

Showing 50 of 61 papers. Every paper with more than 39 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force Praveen Thokala, Nancy J. Devlin, Kevin Marsh et al. · Value in Health Open access 2016 755
2 Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force Kevin Marsh, Maarten J. IJzerman, Praveen Thokala et al. · Value in Health Open access Mar 2016 486
3 A systematic review of the health-related quality of life and economic burdens of anorexia nervosa, bulimia nervosa, and binge eating disorder Tamás Ágh, Gábor László Kovács, Dylan Supina et al. · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity ReviewOpen access 4 Mar 2016 396
4 Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review Erik E. L. Jansen et al. · European Journal of Cancer ReviewOpen access 21 Jan 2020 272
5 Epidemiology, health-related quality of life and economic burden of binge eating disorder: a systematic literature review Tamás Ágh, Gábor László Kovács, Manjiri D. Pawaskar et al. · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity ReviewOpen access 8 Jan 2015 162
6 The effect of social distance measures on COVID-19 epidemics in Europe: an interrupted time series analysis Zoltán Vokó, János György Pitter · GeroScience Open access 11 Jun 2020 159
7 Comparison of weighting methods used in multicriteria decision analysis frameworks in healthcare with focus on low- and middle-income countries Bertalan Németh, Anett Molnár, Sándor Bozóki et al. · Journal of Comparative Effectiveness Research Open access 15 Feb 2019 148
8 Challenges in Research and Health Technology Assessment of Rare Disease Technologies: Report of the ISPOR Rare Disease Special Interest Group Sandra Nestler-Parr, Daria A. Korchagina, Mondher Toumi et al. · Value in Health Open access 11 Apr 2018 143
9 Policy objective of generic medicines from the investment perspective: The case of clopidogrel Péter Elek, András Harsányi, Tamás Zelei et al. · Health Policy 7 Mar 2017 136
10 Burden of Atopic Dermatitis in Adults and Adolescents: a Systematic Literature Review Ahmad Nader Fasseeh, Baher Elezbawy, Nada Korra et al. · Dermatology and Therapy ReviewOpen access 5 Oct 2022 135
11 Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary—the HUN-VE study Zoltán Vokó, Zoltán Kiss, György Surján et al. · Clinical Microbiology and Infection Open access 24 Nov 2021 133
12 Methods for Measuring Multiple Medication Adherence: A Systematic Review–Report of the ISPOR Medication Adherence and Persistence Special Interest Group Priti P. Pednekar, Tamás Ágh, Maria Malmenäs et al. · Value in Health ReviewOpen access 25 Oct 2018 128
13 Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries Tomasz Bochenek et al. · Frontiers in Pharmacology Open access 18 Jan 2018 115
14 Time to do more: Addressing clinical inertia in the management of type 2 diabetes mellitus William David Strain, Xavier Cos, Michael Hirst et al. · Diabetes Research and Clinical Practice Open access 27 May 2014 114
15 The Burden of Obesity in Egypt Mohamed Aboulghate, Aliaa Aly El-Aghoury, Ibrahim Elebrashy et al. · Frontiers in Public Health Open access 27 Aug 2021 89
16 Drivers of successful implementation of integrated care for multi-morbidity: Mechanisms identified in 17 case studies from 8 European countries Willemijn Looman, Verena Struckmann, Julia Köppen et al. · Social Science & Medicine Open access 5 Feb 2021 89
17 Identifying the barriers to effective breast, cervical and colorectal cancer screening in thirty one European countries using the Barriers to Effective Screening Tool (BEST) Jennifer Priaulx, Harry J. de Koning, Inge M.C.M. de Kok et al. · Health Policy Open access 27 Aug 2018 85
18 Digital Health Transformation of Integrated Care in Europe: Overarching Analysis of 17 Integrated Care Programs Erik Baltaxe, Thomas Czypionka, Markus Kraus et al. · Journal of Medical Internet Research Open access 26 Sep 2019 81
19 Epidemiology of Sanfilippo syndrome: results of a systematic literature review Tamás Zelei, Kata Csetneki, Zoltán Vokó et al. · Orphanet Journal of Rare Diseases ReviewOpen access 10 Apr 2018 81
20 Relationship Between Medication Adherence and Health-Related Quality of Life in Subjects With COPD: A Systematic Review Tamás Ágh, Péterné Dömötör, Zoltán Bártfai et al. · Respiratory Care ReviewOpen access 2 Sep 2014 81
21 Systematic review of real-world studies evaluating the impact of medication non-adherence to endocrine therapies on hard clinical endpoints in patients with non-metastatic breast cancer András Inotai, Tamás Ágh, R.F. van Maris et al. · Cancer Treatment Reviews ReviewOpen access 31 Jul 2021 79
22 HTA Implementation Roadmap in Central and Eastern European Countries Zoltán Kaló, Adrian Gheorghe, Mirjana Huić et al. · Health Economics Open access 14 Jan 2016 77
23 Surrogate Endpoints in Health Technology Assessment: An International Review of Methodological Guidelines Bogdan Grigore, Oriana Ciani, Florian Dams et al. · PharmacoEconomics Open access 22 Jun 2020 74
24 Implementation of Health Technology Assessment in the Middle East and North Africa: Comparison Between the Current and Preferred Status Ahmad Nader Fasseeh, Rita Karam, Mouna Jameleddine et al. · Frontiers in Pharmacology Open access 21 Feb 2020 73
25 Systematic literature review and meta-analysis on the epidemiology of methylmalonic acidemia (MMA) with a focus on MMA caused by methylmalonyl-CoA mutase (mut) deficiency Tímea Almási, Lin T. Guey, Christine Lukacs et al. · Orphanet Journal of Rare Diseases ReviewOpen access 25 Apr 2019 72
26 Strengthening the evidence-base of integrated care for people with multi-morbidity in Europe using Multi-Criteria Decision Analysis (MCDA) Maureen Rutten‐van Mölken, Fenna Leijten, Maaike Jennifer Hoedemakers et al. · BMC Health Services Research Open access 24 Jul 2018 71
27 Systematic review on the evaluation criteria of orphan medicines in Central and Eastern European countries Tamás Zelei, Mária Judit Molnár, Márta Szegedi et al. · Orphanet Journal of Rare Diseases ReviewOpen access 4 Jun 2016 68
28 Consolidated Health Economic Evaluation Reporting Standards for Interventions That Use Artificial Intelligence (CHEERS-AI) Jamie Elvidge et al. · Value in Health Open access 23 May 2024 67
29 Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options Rositsa Koleva‐Kolarova, James P. Buchanan, Heleen Vellekoop et al. · Applied Health Economics and Health Policy ReviewOpen access 3 Apr 2022 66
30 Human health risk–benefit assessment of fish and other seafood: a scoping review Sofie Theresa Thomsen, Ricardo Assunção, Cláudia M. Afonso et al. · Critical Reviews in Food Science and Nutrition Open access 6 May 2021 64
31 The European challenges of funding orphan medicinal products Márta Szegedi, Tamás Zelei, Francis Arickx et al. · Orphanet Journal of Rare Diseases Open access 24 Oct 2018 64
32 Healthcare financing in Egypt: a systematic literature review. Ahmad Nader Fasseeh, Baher Elezbawy, Wessam Adly et al. · Journal of the Egyptian Public Health Association ReviewOpen access 7 Jan 2022 61
33 Direct healthcare cost of schizophrenia – European overview Gábor László Kovács, Tímea Almási, A. Millier et al. · European Psychiatry Open access 2018 58
34 Need for Multicriteria Evaluation of Generic Drug Policies Zoltán Kaló, Anke‐Peggy Holtorf, Rafael Alfonso‐Cristancho et al. · Value in Health Open access 11 Feb 2015 56
35 The impact of the war on maintenance of long-term therapies in Ukraine Nataliia Khanyk, Bohdan P. Hromovyk, Оksana Levytska et al. · Frontiers in Pharmacology Open access 24 Nov 2022 55
36 European Network to Advance Best Practices and Technology on Medication Adherence: Mission Statement Job F. M. van Boven, Ioanna Tsiligianni, Ines Potočnjak et al. · Frontiers in Pharmacology Open access 11 Oct 2021 54
37 Principles of pharmacoeconomics and their impact on strategic imperatives of pharmaceutical research and development József Bodrogi, Zoltán Kaló · British Journal of Pharmacology Open access 2 Feb 2010 53
38 Barriers to Use Artificial Intelligence Methodologies in Health Technology Assessment in Central and East European Countries Konstantin Tachkov, Antal Tamás Zemplenyi, Maria Kamusheva et al. · Frontiers in Public Health Open access 14 Jul 2022 52
39 Validity of Surrogate Endpoints and Their Impact on Coverage Recommendations: A Retrospective Analysis across International Health Technology Assessment Agencies Oriana Ciani, Bogdan Grigore, Hedwig M. Blommestein et al. · Medical Decision Making Open access 10 Mar 2021 51
40 Is there a reason for concern or is it just hype? – A systematic literature review of the clinical consequences of switching from originator biologics to biosimilars András Inotai, Christiaan P.J Prins, Marcell Csanádi et al. · Expert Opinion on Biological Therapy Review 26 Jun 2017 50
41 Capacity Building for HTA Implementation in Middle-Income Countries: The Case of Hungary Zoltán Kaló, József Bodrogi, I Boncz et al. · Value in Health Regional Issues Open access 25 Jul 2013 50
42 The Net Benefit of Personalized Medicine: A Systematic Literature Review and Regression Analysis Heleen Vellekoop, Matthijs Versteegh, Simone A. Huygens et al. · Value in Health ReviewOpen access 2 Mar 2022 49
43 External Reference Pricing for Pharmaceuticals—A Survey and Literature Review to Describe Best Practices for Countries With Expanding Healthcare Coverage Anke‐Peggy Holtorf, Fotini Gialama, Kalman Emry Wijaya et al. · Value in Health Regional Issues Open access 12 Aug 2019 49
44 Analysis of Pharmaceutical Industry Payments to UK Health Care Organizations in 2015 Piotr Ozierański, Marcell Csanádi, Emily Rickard et al. · JAMA Network Open Open access 21 Jun 2019 49
45 Differential pricing of new pharmaceuticals in lower income European countries Zoltán Kaló, Lieven Annemans, Louis P. Garrison · Expert Review of Pharmacoeconomics & Outcomes Research 13 Nov 2013 49
46 Nationwide Effectiveness of First and Second SARS-CoV2 Booster Vaccines During the Delta and Omicron Pandemic Waves in Hungary (HUN-VE 2 Study) Zoltán Kiss, István Wittmann, Lőrinc Polivka et al. · Frontiers in Immunology Open access 23 Jun 2022 48
47 A systematic review of the indirect costs of schizophrenia in Europe Ahmad Nader Fasseeh, Bertalan Németh, Anett Molnár et al. · European Journal of Public Health ReviewOpen access 15 Oct 2018 47
48 A systematic review of health economic models and utility estimation methods in schizophrenia Bertalan Németh, Ahmad Nader Fasseeh, Anett Molnár et al. · Expert Review of Pharmacoeconomics & Outcomes Research Review 19 Jan 2018 47
49 Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment Antal Tamás Zemplenyi, Konstantin Tachkov, László Balkányi et al. · Frontiers in Public Health Open access 26 Apr 2023 44
50 Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine Heleen Vellekoop, Simone A. Huygens, Matthijs Versteegh et al. · PharmacoEconomics Open access 16 Apr 2021 44

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.